MAPK1 and Alzheimer disease: In the study by Deng et al. (2020) miR-132 expression was significantly downregulated in an AD rat model, and MAPK1 expression was significantly upregulated; they suggested that miR-132 and MAPK1 had specific binding sites, and that miR-132 could inhibit MAPK1 expression.